This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Digital HealthTechnologies ( DHTs ) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collection of real-world data outside traditional clinical settings.
In addition, MDisrupt will add new features to the marketplace platform through a strategic collaboration with the Association to meet the needs of its members, providing new ways for them to engage with the healthtechnology, health services, medical device, and lifesciences sectors.
.–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. The technologies have already been used in the successful delivery of multiple AstraZeneca-sponsored clinical trials in over 40 countries.
The key trends that are expected to shape the market in 2023 include: Increased focus on digital health: Healthcare companies are increasingly looking to acquire digital health businesses in order to improve their offerings and stay ahead of the competition. Engage with the HealthTech Community Thoughts, comments?
Top Headlines VC firm General Catalyst is creating Health Assurance Transformation Corp., which will partner with 20+ health system partners to guide their transition to value-based care and potentially acquire a health system “where we can demonstrate the blueprint of this transformation for the rest of the industry.”
It is also worth noting that Scotland's healthtech ecosystem is well-supported by a number of government and industry initiatives, such as the Scottish National Health Service (NHS) Scotland Health Innovation Hub and the LifeSciences Scotland industry body. The company raised $10m in 2022.
It is also worth noting that Scotland's healthtech ecosystem is well-supported by a number of government and industry initiatives, such as the Scottish National Health Service (NHS) Scotland Health Innovation Hub and the LifeSciences Scotland industry body. The company raised $10m in 2022.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content